PubMed:8824287
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-78 | Sentence | denotes | JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes. |
| T2 | 79-213 | Sentence | denotes | AP-1 has been shown to behave as a redox-sensitive transcription factor that can be activated by both oxidant and antioxidant stimuli. |
| T3 | 214-309 | Sentence | denotes | However, the mechanisms involved in the activation of AP-1 by antioxidants are largely unknown. |
| T4 | 310-525 | Sentence | denotes | In this study we show that the structurally unrelated antioxidant agents pyrrolidine dithiocarbamate (PDTC), butylated hydroxyanisole, and Nacetylcysteine activated JNK (c-Jun NH2-terminal kinase) in Jurkat T cells. |
| T5 | 526-741 | Sentence | denotes | This activation differed substantially from that mediated by phorbol 12-myristate 13-acetate (PMA) and Ca2+ ionophore or produced by costimulation with antibodies against the T cell receptor-CD3 complex and to CD28. |
| T6 | 742-907 | Sentence | denotes | The activation of JNK by classical T cell stimuli was transient, whereas that mediated by PDTC and butylated hydroxyanisole (but not N-acetylcysteine) was sustained. |
| T7 | 908-1113 | Sentence | denotes | The kinetics of JNK activation correlated with the expression of c-jun which was transient after stimulation with PMA plus ionophore and prolonged in response to PDTC, which also transiently induced c-fos. |
| T8 | 1114-1334 | Sentence | denotes | In addition, JNK activation by PMA plus ionophore was sensitive to inhibitors of signaling pathways involving Ca2+, protein kinase C, and tyrosine phosphorylation, which failed to inhibit the activation mediated by PDTC. |
| T9 | 1335-1655 | Sentence | denotes | Transfection of trans-dominant negative expression vectors of ras and raf, together with AP-1-dependent reporter constructs, as well as Western blot analysis using anti-ERK (extracellular signal-regulated kinase) antibodies, indicated that the Ras/Raf/ERK pathway did not appear to mediate the effect of the antioxidant. |
| T10 | 1656-1805 | Sentence | denotes | However, the combined treatment with PDTC and PMA, two agents that synergize on AP-1 activation, resulted in the persistent phosphorylation of ERK-2. |
| T11 | 1806-1959 | Sentence | denotes | In conclusion, our results identify JNK as a target of antioxidant agents which can be regulated differentially under oxidant and antioxidant conditions. |
| T1 | 0-78 | Sentence | denotes | JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes. |
| T2 | 79-213 | Sentence | denotes | AP-1 has been shown to behave as a redox-sensitive transcription factor that can be activated by both oxidant and antioxidant stimuli. |
| T3 | 214-309 | Sentence | denotes | However, the mechanisms involved in the activation of AP-1 by antioxidants are largely unknown. |
| T4 | 310-525 | Sentence | denotes | In this study we show that the structurally unrelated antioxidant agents pyrrolidine dithiocarbamate (PDTC), butylated hydroxyanisole, and Nacetylcysteine activated JNK (c-Jun NH2-terminal kinase) in Jurkat T cells. |
| T5 | 526-741 | Sentence | denotes | This activation differed substantially from that mediated by phorbol 12-myristate 13-acetate (PMA) and Ca2+ ionophore or produced by costimulation with antibodies against the T cell receptor-CD3 complex and to CD28. |
| T6 | 742-907 | Sentence | denotes | The activation of JNK by classical T cell stimuli was transient, whereas that mediated by PDTC and butylated hydroxyanisole (but not N-acetylcysteine) was sustained. |
| T7 | 908-1113 | Sentence | denotes | The kinetics of JNK activation correlated with the expression of c-jun which was transient after stimulation with PMA plus ionophore and prolonged in response to PDTC, which also transiently induced c-fos. |
| T8 | 1114-1334 | Sentence | denotes | In addition, JNK activation by PMA plus ionophore was sensitive to inhibitors of signaling pathways involving Ca2+, protein kinase C, and tyrosine phosphorylation, which failed to inhibit the activation mediated by PDTC. |
| T9 | 1335-1655 | Sentence | denotes | Transfection of trans-dominant negative expression vectors of ras and raf, together with AP-1-dependent reporter constructs, as well as Western blot analysis using anti-ERK (extracellular signal-regulated kinase) antibodies, indicated that the Ras/Raf/ERK pathway did not appear to mediate the effect of the antioxidant. |
| T10 | 1656-1805 | Sentence | denotes | However, the combined treatment with PDTC and PMA, two agents that synergize on AP-1 activation, resulted in the persistent phosphorylation of ERK-2. |
| T11 | 1806-1959 | Sentence | denotes | In conclusion, our results identify JNK as a target of antioxidant agents which can be regulated differentially under oxidant and antioxidant conditions. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-3 | protein | denotes | JNK |
| T2 | 5-30 | protein | denotes | c-Jun NH2-terminal kinase |
| T3 | 64-77 | cell_type | denotes | T lymphocytes |
| T4 | 79-83 | protein | denotes | AP-1 |
| T5 | 114-150 | protein | denotes | redox-sensitive transcription factor |
| T6 | 268-272 | protein | denotes | AP-1 |
| T7 | 475-478 | protein | denotes | JNK |
| T8 | 480-505 | protein | denotes | c-Jun NH2-terminal kinase |
| T9 | 510-524 | cell_line | denotes | Jurkat T cells |
| T10 | 678-688 | protein | denotes | antibodies |
| T11 | 701-728 | protein | denotes | T cell receptor-CD3 complex |
| T12 | 736-740 | protein | denotes | CD28 |
| T13 | 760-763 | protein | denotes | JNK |
| T14 | 924-927 | protein | denotes | JNK |
| T15 | 973-978 | DNA | denotes | c-jun |
| T16 | 1107-1112 | DNA | denotes | c-fos |
| T17 | 1127-1130 | protein | denotes | JNK |
| T18 | 1230-1246 | protein | denotes | protein kinase C |
| T19 | 1351-1393 | DNA | denotes | trans-dominant negative expression vectors |
| T20 | 1397-1400 | DNA | denotes | ras |
| T21 | 1405-1408 | DNA | denotes | raf |
| T22 | 1424-1458 | DNA | denotes | AP-1-dependent reporter constructs |
| T23 | 1499-1558 | protein | denotes | anti-ERK (extracellular signal-regulated kinase) antibodies |
| T24 | 1736-1740 | protein | denotes | AP-1 |
| T25 | 1799-1804 | protein | denotes | ERK-2 |
| T26 | 1842-1845 | protein | denotes | JNK |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-78 | Sentence | denotes | JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes. |
| S2 | 79-213 | Sentence | denotes | AP-1 has been shown to behave as a redox-sensitive transcription factor that can be activated by both oxidant and antioxidant stimuli. |
| S3 | 214-309 | Sentence | denotes | However, the mechanisms involved in the activation of AP-1 by antioxidants are largely unknown. |
| S4 | 310-525 | Sentence | denotes | In this study we show that the structurally unrelated antioxidant agents pyrrolidine dithiocarbamate (PDTC), butylated hydroxyanisole, and Nacetylcysteine activated JNK (c-Jun NH2-terminal kinase) in Jurkat T cells. |
| S5 | 526-741 | Sentence | denotes | This activation differed substantially from that mediated by phorbol 12-myristate 13-acetate (PMA) and Ca2+ ionophore or produced by costimulation with antibodies against the T cell receptor-CD3 complex and to CD28. |
| S6 | 742-907 | Sentence | denotes | The activation of JNK by classical T cell stimuli was transient, whereas that mediated by PDTC and butylated hydroxyanisole (but not N-acetylcysteine) was sustained. |
| S7 | 908-1113 | Sentence | denotes | The kinetics of JNK activation correlated with the expression of c-jun which was transient after stimulation with PMA plus ionophore and prolonged in response to PDTC, which also transiently induced c-fos. |
| S8 | 1114-1334 | Sentence | denotes | In addition, JNK activation by PMA plus ionophore was sensitive to inhibitors of signaling pathways involving Ca2+, protein kinase C, and tyrosine phosphorylation, which failed to inhibit the activation mediated by PDTC. |
| S9 | 1335-1655 | Sentence | denotes | Transfection of trans-dominant negative expression vectors of ras and raf, together with AP-1-dependent reporter constructs, as well as Western blot analysis using anti-ERK (extracellular signal-regulated kinase) antibodies, indicated that the Ras/Raf/ERK pathway did not appear to mediate the effect of the antioxidant. |
| S10 | 1656-1805 | Sentence | denotes | However, the combined treatment with PDTC and PMA, two agents that synergize on AP-1 activation, resulted in the persistent phosphorylation of ERK-2. |
| S11 | 1806-1959 | Sentence | denotes | In conclusion, our results identify JNK as a target of antioxidant agents which can be regulated differentially under oxidant and antioxidant conditions. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C7 | 0-31 | NP | denotes | JNK (c-Jun NH2-terminal kinase) |
| C3 | 48-77 | NP | denotes | antioxidants in T lymphocytes |
| C39 | 35-77 | NP | denotes | a target for antioxidants in T lymphocytes |
| C5 | 79-83 | NP | denotes | AP-1 |
| C1 | 112-150 | NP | denotes | a redox-sensitive transcription factor |
| C2 | 151-155 | NP | denotes | that |
| C6 | 268-272 | NP | denotes | AP-1 |
| C4 | 276-288 | NP | denotes | antioxidants |
| C16 | 383-417 | NP | denotes | pyrrolidine dithiocarbamate (PDTC) |
| C18 | 419-443 | NP | denotes | butylated hydroxyanisole |
| C8 | 475-524 | NP | denotes | JNK (c-Jun NH2-terminal kinase) in Jurkat T cells |
| C9 | 526-541 | NP | denotes | This activation |
| C10 | 570-574 | NP | denotes | that |
| C30 | 587-624 | NP | denotes | phorbol 12-myristate 13-acetate (PMA) |
| C27 | 587-643 | NP | denotes | phorbol 12-myristate 13-acetate (PMA) and Ca2+ ionophore |
| C12 | 742-756 | NP | denotes | The activation |
| C11 | 760-763 | NP | denotes | JNK |
| C13 | 815-819 | NP | denotes | that |
| C17 | 832-836 | NP | denotes | PDTC |
| C19 | 841-865 | NP | denotes | butylated hydroxyanisole |
| C14 | 955-978 | NP | denotes | the expression of c-jun |
| C15 | 979-984 | NP | denotes | which |
| C29 | 1022-1025 | NP | denotes | PMA |
| C28 | 1022-1040 | NP | denotes | PMA plus ionophore |
| C20 | 1070-1074 | NP | denotes | PDTC |
| C21 | 1076-1081 | NP | denotes | which |
| C31 | 1145-1148 | NP | denotes | PMA |
| C26 | 1145-1163 | NP | denotes | PMA plus ionophore |
| C23 | 1181-1276 | NP | denotes | inhibitors of signaling pathways involving Ca2+, protein kinase C, and tyrosine phosphorylation |
| C24 | 1278-1283 | NP | denotes | which |
| C22 | 1329-1333 | NP | denotes | PDTC |
| C36 | 1693-1697 | NP | denotes | PDTC |
| C32 | 1702-1705 | NP | denotes | PMA |
| C25 | 1693-1705 | NP | denotes | PDTC and PMA |
| C35 | 1707-1717 | NP | denotes | two agents |
| C34 | 1718-1722 | NP | denotes | that |
| C33 | 1707-1751 | NP | denotes | two agents that synergize on AP-1 activation |
| C37 | 1842-1845 | NP | denotes | JNK |
| C38 | 1849-1879 | NP | denotes | a target of antioxidant agents |
| C40 | 1880-1885 | NP | denotes | which |
| R1 | C2 | C1 | coref-relat | that,a redox-sensitive transcription factor |
| R2 | C6 | C5 | coref-ident | AP-1,AP-1 |
| R3 | C4 | C3 | coref-ident | antioxidants,antioxidants in T lymphocytes |
| R4 | C8 | C7 | coref-ident | JNK (c-Jun NH2-terminal kinase) in Jurkat T cells,JNK (c-Jun NH2-terminal kinase) |
| R5 | C10 | C9 | coref-pron | that,This activation |
| R6 | C11 | C8 | coref-ident | JNK,JNK (c-Jun NH2-terminal kinase) in Jurkat T cells |
| R7 | C13 | C12 | coref-xxx | that,The activation |
| R8 | C17 | C16 | coref-ident | PDTC,pyrrolidine dithiocarbamate (PDTC) |
| R9 | C19 | C18 | coref-ident | butylated hydroxyanisole,butylated hydroxyanisole |
| R10 | C15 | C14 | coref-relat | which,the expression of c-jun |
| R11 | C29 | C30 | coref-ident | PMA,phorbol 12-myristate 13-acetate (PMA) |
| R12 | C28 | C27 | coref-ident | PMA plus ionophore,phorbol 12-myristate 13-acetate (PMA) and Ca2+ ionophore |
| R13 | C20 | C17 | coref-ident | PDTC,PDTC |
| R14 | C21 | C20 | coref-relat | which,PDTC |
| R15 | C31 | C29 | coref-ident | PMA,PMA |
| R16 | C26 | C28 | coref-ident | PMA plus ionophore,PMA plus ionophore |
| R17 | C24 | C23 | coref-relat | which,"inhibitors of signaling pathways involving Ca2+, protein kinase C, and tyrosine phosphorylation" |
| R18 | C22 | C20 | coref-ident | PDTC,PDTC |
| R19 | C32 | C26 | coref-ident | PMA,PMA plus ionophore |
| R20 | C25 | C22 | coref-ident | PDTC and PMA,PDTC |
| R21 | C35 | C36 | coref-appos | two agents,PDTC |
| R22 | C34 | C33 | coref-relat | that,two agents that synergize on AP-1 activation |
| R23 | C37 | C11 | coref-ident | JNK,JNK |
| R24 | C38 | C39 | coref-ident | a target of antioxidant agents,a target for antioxidants in T lymphocytes |
| R25 | C40 | C38 | coref-relat | which,a target of antioxidant agents |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-3 | protein_molecule | denotes | JNK |
| T2 | 5-30 | protein_molecule | denotes | c-Jun NH2-terminal kinase |
| T3 | 48-60 | other_organic_compound | denotes | antioxidants |
| T4 | 64-77 | cell_type | denotes | T lymphocytes |
| T5 | 79-83 | protein_molecule | denotes | AP-1 |
| T6 | 114-150 | protein_family_or_group | denotes | redox-sensitive transcription factor |
| T7 | 268-272 | protein_molecule | denotes | AP-1 |
| T8 | 276-288 | other_organic_compound | denotes | antioxidants |
| T9 | 383-410 | other_organic_compound | denotes | pyrrolidine dithiocarbamate |
| T10 | 412-416 | other_organic_compound | denotes | PDTC |
| T11 | 419-443 | other_organic_compound | denotes | butylated hydroxyanisole |
| T12 | 449-464 | amino_acid_monomer | denotes | Nacetylcysteine |
| T13 | 475-478 | protein_molecule | denotes | JNK |
| T14 | 480-505 | protein_molecule | denotes | c-Jun NH2-terminal kinase |
| T15 | 510-524 | cell_line | denotes | Jurkat T cells |
| T16 | 587-618 | other_organic_compound | denotes | phorbol 12-myristate 13-acetate |
| T17 | 620-623 | other_organic_compound | denotes | PMA |
| T18 | 629-633 | atom | denotes | Ca2+ |
| T19 | 678-688 | protein_family_or_group | denotes | antibodies |
| T20 | 701-728 | protein_complex | denotes | T cell receptor-CD3 complex |
| T21 | 736-740 | protein_molecule | denotes | CD28 |
| T22 | 760-763 | protein_molecule | denotes | JNK |
| T23 | 767-791 | other_name | denotes | classical T cell stimuli |
| T24 | 832-836 | other_organic_compound | denotes | PDTC |
| T25 | 841-865 | other_organic_compound | denotes | butylated hydroxyanisole |
| T26 | 875-891 | amino_acid_monomer | denotes | N-acetylcysteine |
| T27 | 924-927 | protein_molecule | denotes | JNK |
| T28 | 973-978 | DNA_domain_or_region | denotes | c-jun |
| T29 | 1022-1025 | other_organic_compound | denotes | PMA |
| T30 | 1070-1074 | other_organic_compound | denotes | PDTC |
| T31 | 1107-1112 | DNA_domain_or_region | denotes | c-fos |
| T32 | 1127-1130 | protein_molecule | denotes | JNK |
| T33 | 1145-1148 | other_organic_compound | denotes | PMA |
| T34 | 1224-1228 | atom | denotes | Ca2+ |
| T35 | 1230-1246 | protein_molecule | denotes | protein kinase C |
| T36 | 1329-1333 | other_organic_compound | denotes | PDTC |
| T37 | 1351-1393 | DNA_molecule | denotes | trans-dominant negative expression vectors |
| T38 | 1397-1400 | DNA_domain_or_region | denotes | ras |
| T39 | 1405-1408 | DNA_domain_or_region | denotes | raf |
| T40 | 1424-1428 | protein_molecule | denotes | AP-1 |
| T41 | 1471-1492 | other_name | denotes | Western blot analysis |
| T42 | 1499-1509 | protein_family_or_group | denotes | anti-ERK ( |
| T43 | 1509-1546 | protein_molecule | denotes | extracellular signal-regulated kinase |
| T44 | 1693-1697 | other_organic_compound | denotes | PDTC |
| T45 | 1702-1705 | other_organic_compound | denotes | PMA |
| T46 | 1736-1740 | protein_molecule | denotes | AP-1 |
| T47 | 1799-1804 | protein_molecule | denotes | ERK-2 |
| T48 | 1842-1845 | protein_molecule | denotes | JNK |
| T49 | 1861-1879 | other_organic_compound | denotes | antioxidant agents |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 620-623 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T3 | 1022-1025 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T5 | 1145-1148 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T7 | 1702-1705 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 64-77 | Body_part | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL_0000084 |
| T2 | 701-707 | Body_part | denotes | T cell | http://purl.obolibrary.org/obo/CL_0000084 |
| T3 | 777-783 | Body_part | denotes | T cell | http://purl.obolibrary.org/obo/CL_0000084 |
| T4 | 1509-1522 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 64-77 | Cell | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL:0000084 |
| T2 | 517-524 | Cell | denotes | T cells | http://purl.obolibrary.org/obo/CL:0000084 |
| T3 | 701-707 | Cell | denotes | T cell | http://purl.obolibrary.org/obo/CL:0000084 |
| T4 | 777-783 | Cell | denotes | T cell | http://purl.obolibrary.org/obo/CL:0000084 |